These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 29673667)
1. The role of preoperative serum cancer antigen 125 in malignant ovarian germ cell tumors. Kim JH; Park JY; Kim JH; Kim YM; Kim YT; Nam JH Taiwan J Obstet Gynecol; 2018 Apr; 57(2):236-240. PubMed ID: 29673667 [TBL] [Abstract][Full Text] [Related]
2. Tissue AP-2gamma and Oct-3/4, and serum CA 125 as diagnostic and prognostic markers of malignant ovarian germ cell tumors. Salonen J; Leminen A; Stenman UH; Butzow R; Heikinheimo M; Heikinheimo O Tumour Biol; 2008; 29(1):50-6. PubMed ID: 18497549 [TBL] [Abstract][Full Text] [Related]
3. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors. Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535 [TBL] [Abstract][Full Text] [Related]
4. Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma? Saygili U; Guclu S; Uslu T; Erten O; Demir N; Onvural A Gynecol Oncol; 2002 Jul; 86(1):57-61. PubMed ID: 12079301 [TBL] [Abstract][Full Text] [Related]
5. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors. Lenhard MS; Nehring S; Nagel D; Mayr D; Kirschenhofer A; Hertlein L; Friese K; Stieber P; Burges A Clin Chem Lab Med; 2009; 47(5):537-42. PubMed ID: 19317653 [TBL] [Abstract][Full Text] [Related]
7. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors. Qin B; Xu W; Li Y Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer. Lin YH; Wu CH; Fu HC; Chen YJ; Chen YY; Ou YC; Lin H Cancer Biomark; 2020; 28(3):285-292. PubMed ID: 32390605 [TBL] [Abstract][Full Text] [Related]
9. Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study. Vorgias G; Iavazzo C; Savvopoulos P; Myriokefalitaki E; Katsoulis M; Kalinoglou N; Akrivos T Gynecol Oncol; 2009 Jan; 112(1):11-5. PubMed ID: 19119502 [TBL] [Abstract][Full Text] [Related]
10. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery. Yang ZJ; Liu ZC; Wei RJ; Li L Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958 [TBL] [Abstract][Full Text] [Related]
11. Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers. Gomes TA; Campos EA; Yoshida A; Sarian LO; Andrade LALA; Derchain SF Rev Bras Ginecol Obstet; 2020 Sep; 42(9):555-561. PubMed ID: 32992358 [TBL] [Abstract][Full Text] [Related]
12. The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours. Zhao T; Zhang H; Liu Y; Jiang H; Wang X; Lu Y Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):398-402. PubMed ID: 27135780 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801). Tang A; Kondalsamy-Chennakesavan S; Ngan H; Zusterzeel P; Quinn M; Carter J; Leung Y; Obermair A Gynecol Oncol; 2012 Jul; 126(1):36-40. PubMed ID: 22370601 [TBL] [Abstract][Full Text] [Related]
14. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403 [TBL] [Abstract][Full Text] [Related]
15. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis. Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278 [TBL] [Abstract][Full Text] [Related]
16. Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer. Muallem MZ; Parashkevova A; Almuheimid J; Richter R; Diab Y; Braicu EI; Sehouli J Anticancer Res; 2017 Jun; 37(6):3157-3161. PubMed ID: 28551658 [TBL] [Abstract][Full Text] [Related]
17. Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. Arits AH; Stoot JE; Botterweck AA; Roumen FJ; Voogd AC Int J Gynecol Cancer; 2008; 18(4):621-8. PubMed ID: 17868339 [TBL] [Abstract][Full Text] [Related]
18. Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level. Obeidat B; Latimer J; Crawford R Gynecol Obstet Invest; 2004; 57(3):153-6. PubMed ID: 14726621 [TBL] [Abstract][Full Text] [Related]
19. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes. Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909 [TBL] [Abstract][Full Text] [Related]
20. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI. Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]